SK Chemicals signs joint sales agreement of ‘Forsteo’ with Lilly Korea

SK Chemicals announced the company signed a joint sales agreement of ‘Forsteo Inj(generic name: teriparatide),’ a medicine stimulating bone formation, with Lilly Korea on the 19th.

Forsteo is the world’s first medicine stimulating bone formation which suggested a new treatment paradigm to help osteoporosis patients form bones. While existing antiresorptive therapies inhibits release of calcium...